Benitec Biopharma Inc.
BNTC
$12.37
-$0.63-4.85%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 78.37% | 141.16% | 39.27% | 92.16% | 632.40% |
| Total Receivables | 0.00% | 6,400.00% | 75.00% | -85.59% | -94.34% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 215.51% | 53.55% | 12.68% | 21.71% | 129.94% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 80.95% | 82.26% | 76.56% | 79.37% | 384.62% |
| Total Current Assets | 78.85% | 140.87% | 39.14% | 90.65% | 624.00% |
|
|
|||||
| Total Current Assets | 78.85% | 140.87% | 39.14% | 90.65% | 624.00% |
| Net Property, Plant & Equipment | -17.40% | 254.17% | 143.85% | 120.71% | 105.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -25.56% | -1.49% | -7.41% | -4.60% | -4.26% |
| Total Assets | 77.74% | 141.16% | 39.63% | 90.75% | 601.44% |
|
|
|||||
| Total Accounts Payable | 46.65% | 71.33% | -69.99% | -85.12% | -46.87% |
| Total Accrued Expenses | -19.74% | -8.05% | -1.91% | -19.01% | 28.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 39.31% | 241.61% | 96.21% | 24.65% | 18.49% |
| Total Finance Division Other Current Liabilities | -72.73% | -58.53% | -77.08% | -72.63% | 223.98% |
| Total Other Current Liabilities | -72.73% | -58.53% | -77.08% | -72.63% | 223.98% |
| Total Current Liabilities | -53.40% | -9.32% | -55.52% | -63.40% | 104.42% |
|
|
|||||
| Total Current Liabilities | -53.40% | -9.32% | -55.52% | -63.40% | 104.42% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -35.73% | -- | -- | -- | 888.71% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -51.98% | 6.17% | -47.15% | -53.71% | 118.32% |
|
|
|||||
| Common Stock & APIC | 43.47% | 56.54% | 27.26% | 36.88% | 57.32% |
| Retained Earnings | -23.06% | -22.85% | -21.41% | -19.93% | -14.66% |
| Treasury Stock & Other | -32.96% | -28.34% | 24.47% | 5.94% | 14.25% |
| Total Common Equity | 87.90% | 146.72% | 45.84% | 105.92% | 748.43% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 87.90% | 146.72% | 45.84% | 105.92% | 748.43% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 87.90% | 146.72% | 45.84% | 105.92% | 748.43% |
|
|
|||||